Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.382
AS - Asia 9.124
EU - Europa 8.443
SA - Sud America 1.272
Continente sconosciuto - Info sul continente non disponibili 906
AF - Africa 201
OC - Oceania 31
Totale 36.359
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.559
SG - Singapore 3.105
IT - Italia 2.641
CN - Cina 1.997
VN - Vietnam 1.442
DE - Germania 1.140
HK - Hong Kong 1.075
RU - Federazione Russa 956
BR - Brasile 940
SE - Svezia 758
IE - Irlanda 734
CA - Canada 684
GB - Regno Unito 464
FR - Francia 356
IN - India 302
AT - Austria 286
UA - Ucraina 263
BD - Bangladesh 218
FI - Finlandia 173
KR - Corea 147
ES - Italia 131
ID - Indonesia 127
NL - Olanda 118
AR - Argentina 108
PL - Polonia 103
IQ - Iraq 95
TR - Turchia 92
DK - Danimarca 89
JP - Giappone 85
MX - Messico 70
ZA - Sudafrica 70
PK - Pakistan 55
EC - Ecuador 53
SA - Arabia Saudita 52
BE - Belgio 48
PH - Filippine 48
UZ - Uzbekistan 42
VE - Venezuela 42
CH - Svizzera 41
MA - Marocco 39
CO - Colombia 38
AU - Australia 28
CL - Cile 27
IR - Iran 27
MY - Malesia 24
CZ - Repubblica Ceca 22
LT - Lituania 22
EG - Egitto 19
PE - Perù 19
RO - Romania 19
IL - Israele 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 17
UY - Uruguay 16
JO - Giordania 15
ET - Etiopia 14
KZ - Kazakistan 14
TW - Taiwan 14
DZ - Algeria 12
KE - Kenya 12
TH - Thailandia 12
DO - Repubblica Dominicana 11
HN - Honduras 11
BO - Bolivia 10
EU - Europa 10
PS - Palestinian Territory 10
BG - Bulgaria 9
CR - Costa Rica 9
KG - Kirghizistan 9
NP - Nepal 9
PA - Panama 9
PT - Portogallo 9
GR - Grecia 8
LB - Libano 8
LV - Lettonia 8
TN - Tunisia 8
JM - Giamaica 7
OM - Oman 7
AL - Albania 6
NO - Norvegia 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
BY - Bielorussia 5
HR - Croazia 5
MN - Mongolia 5
QA - Qatar 5
RS - Serbia 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
BB - Barbados 4
KH - Cambogia 4
MT - Malta 4
NG - Nigeria 4
SN - Senegal 4
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
Totale 35.417
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.129
Singapore 1.817
Ashburn 1.675
San Jose 1.213
Milan 1.064
Hong Kong 1.041
Fairfield 775
Dublin 724
Chandler 722
Frankfurt am Main 666
Woodbridge 626
Houston 549
Wilmington 532
Ho Chi Minh City 443
New York 432
Toronto 425
Dallas 408
Los Angeles 374
Dearborn 358
Santa Clara 355
Hanoi 340
Seattle 332
Beijing 276
Vienna 251
Cambridge 245
Jacksonville 236
Chicago 220
Hefei 191
Shanghai 185
The Dalles 184
Princeton 177
São Paulo 140
Nanjing 136
Seoul 129
Buffalo 123
Rome 122
Council Bluffs 121
Lauterbourg 111
Columbus 101
Orem 101
Boardman 93
Moscow 93
Munich 86
Helsinki 79
Jakarta 73
Montreal 66
London 65
Da Nang 64
Lawrence 63
Warsaw 63
Altamura 62
Brooklyn 61
Guangzhou 61
Fremont 59
Kent 59
Nanchang 58
Denver 56
Tokyo 54
North Kansas City 50
Atlanta 49
Dong Ket 48
Nuremberg 47
Chennai 46
Baghdad 43
Haiphong 43
San Diego 43
Amsterdam 42
Brussels 42
Stockholm 42
Ottawa 41
Lachine 40
Johannesburg 39
Montréal 38
San Francisco 38
Tashkent 38
Turin 37
Rio de Janeiro 34
Washington 34
Hải Dương 33
Phoenix 33
Turku 33
Shenyang 32
Boston 31
Manchester 31
Biên Hòa 29
Changsha 29
Florence 29
Paris 29
Zhengzhou 29
Newark 28
Figino 27
Lissone 27
Ninh Bình 27
Salt Lake City 27
Naples 26
Poplar 26
Tianjin 26
Zurich 26
Andover 25
Pune 24
Totale 22.725
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 602
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 589
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 575
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 567
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 546
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 522
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 493
Differential protein profiling of renal cell carcinoma urinary exosomes 476
Urinary exosomes and diabetic nephropathy: a proteomic approach 461
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 460
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 455
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 446
The putative role of MALDI-MSI in the study of Membranous Nephropathy 439
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 428
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 425
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 423
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 420
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 414
The proteomic landscape of renal tumors 412
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 390
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 384
Mutual Information Optimization for Mass Spectra Data Alignment 382
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 378
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 378
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 377
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 376
Proteomics imaging and the kidney 373
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 367
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 367
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 366
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 364
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 360
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 358
Robust conclusions in mass spectrometry analysis 354
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 354
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 353
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 343
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 339
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 338
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 336
Poster: Characterization of distinguishing regions for renal cell carcinoma discrimination 336
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 336
Proteome analysis in thyroid pathology 333
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 333
Tumor size, stage and grade alterations of urinary peptidome in RCC 330
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 322
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 315
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 314
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 313
Analysis of correlation structures in renal cell carcinoma patient data 313
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 306
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 305
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 301
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 297
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 296
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 293
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 291
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 290
A molecular imaging approach to individuate tumour infiltrating lymphocytes 290
Intraluminal proteome and peptidome of human urinary extracellular vesicles 289
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 286
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 286
Imaging mass spectrometry: a new tool for kidney disease investigations 285
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 285
AQP1 expression analysis in human diseases: Implications for proteomic characterization 283
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 281
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 278
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 276
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 275
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 272
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 268
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 265
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 257
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 254
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 253
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 249
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 247
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 242
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 241
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 240
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 239
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 237
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 236
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 234
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 229
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 216
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 215
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 213
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 209
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 205
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 203
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 202
Immunoreattività e carcinoma renale 200
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 196
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 193
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 191
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 189
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 189
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 186
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 186
Totale 32.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.003
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.394 0 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20255.434 222 473 345 220 481 215 318 222 558 943 587 850
2025/202614.914 1.940 753 1.169 1.689 1.665 717 2.152 552 1.055 1.252 994 976
2026/2027655 473 182 0 0 0 0 0 0 0 0 0 0
Totale 36.359